Deok Won Hwang

Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung Cancer

Jong‐Mu Sun, Deok Won Hwang, Jin Seok Ahn et al. · PLoS ONE · 2013 · 84 citations · Full text

Medicine, Genetics, Oncology +15

Gemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphoma

Hee Kyung Ahn, Seok Jin Kim, Deok Won Hwang et al. · Investigational New Drugs · 2012 · 57 citations

Medicine, Oncology, Pharmacotherapy +8

The impact of baseline and interim PET/CT parameters on clinical outcome in patients with diffuse large B cell lymphoma

Silvia Park, Seung Hwan Moon, Lee Chun Park et al. · American Journal of Hematology · 2012 · 49 citations · Full text

Medicine, Oncology, Radiology +16

A prospective multicentre phase II study of cisplatin and weekly docetaxel as first-line treatment for recurrent or metastatic nasopharyngeal cancer (KCSG HN07-01)

Jun Ho Ji, Tak Yun, Sung‐Bae Kim et al. · European Journal of Cancer · 2012 · 25 citations · Full text

Medicine, Oncology, Pharmacology +11

Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma NSCLC patients with EGFR mutation

Su-Hee Cho, Lee Chun Park, Jun Ho Ji et al. · Cancer Chemotherapy and Pharmacology · 2012 · 20 citations

Medicine, Oncology, Pharmacology +16